News
Venture Challenge alumnus Core Life Analytics signes collaboration with Molecule Devices
Molecular Devices and Core Life Analytics collaborate, adding the StratoMineR cloud-powered data analytics software to Molecular Devices' high-content portfolio Complementing Molecular Devices’ high-content imaging workflow, StratoMineR intuit
€5 Million for Venture Challenge Alumnus Prolira
In 2014, Prolira participated in the Venture Challenge as a start-up. Now, years later, the announcement has been made that several parties together invest €5 million in the scale-up to further help hospital departments improve patient care in the field of acute brain failure (acute encephalopathy and delirium).
Apply For The Henri Termeer Transatlantic Connections Award 2022
Are you the next emerging biotech entrepreneur in the Netherlands? And do you want access to experienced life science mentors, networking with fellow peer entrepreneurs and do you want to have an inside look in the Massachusetts life sciences sector?
River BioMedics secures €1.8 mln seed investment to Progress its Cardiovascular Disease Programs
Venture Challenge alumnus River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its pipeline of cardiovascular disease targets and compounds
NutriLeads’ clinical trial demonstrates that daily intake of BeniCaros helps support protective innate immune responses
Pivotal study published in Nutrients showing that Nutrileads’ proprietary carrot-derived rhamnogalacturonan-I (cRG-I) (commercially known as BeniCaros) fiber, accelerates protective anti-viral immune responses and reduces symptoms after an exper
Incircular awarded €2.5 mln EIC Transition Grant
Venture Challenge alumnus Incircular was one of the 42 projects that received a EIC transition grant in the first ever round of this new scheme to support projects to take breakthrough technologies from the lab into the real world.
Predica Diagnostics and TenWise announce collaboration on development of MicroBioDx, a novel microbiome-host profiling tool for health and disease
Leiden/Nijmegen - TenWise BV and Venture Challenge alumnus Predica Diagnostics BV have received financial support from the Dutch RVO (
Venture Challenge Winner Ambagon Therapeutics Raises $85mln Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
San Fransisco / Eindhoven – Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, today announced an $85 million Series A to augment its
SeraNovo and Graviton deepen collaboration and enter into a second license agreement to develop formulations for Graviton's ROCK-2 inhibitors
Venture Challenge Winner SeraNovo is pleased to announce the closing of a second license agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncol
NTRC announces IND approval for the TTK/PLK dual inhibitor BAL0891 in its collaboration with Swiss pharmaceutical company Basilea
Oss – Venture Challenge alumnus NTRC, specialized in discovery and development of innovative kinase inhibitors to treat cancer patients, today announces that the U.S.